The experience at our center suggests that VA-ECMO, despite a high risk of complications, is a potentially effective bridge to definitive therapy in select cases of cardiac arrest and refractory cardiogenic.This may be in part due to selection of younger and healthier patients with greater emphasis on those with IHCA and cardiogenic shock.